2[2]Elkin I,Shea MT,Watkins JT,et al.Nutional institute of mental health teatment of depression CoUaborative research progam:General effeetiveness of treatments.Aroh Gen Psychiatry 2002;46:971-83
4Tollefson GD, Sanger TM, Beasley CM,et al.A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.Biol Psychiatry 1998;43(11):803-10
5Shelton RC, Tollefson GD, Tohen M,et al.A novel augmentation strategy for reating resistant major depression.Am J Psychiatry 2001;158(1):131-4
6Alexopoulos GS, Meyers BS, Young RC,et al.Vascular depression＇hypothesis.Arch Gen Psychiatry 1997;54(10):915-22
7Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968; 13(3): 222-57.
8Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229 (2):327- 36.
9Steru L, Chermat R, Thierry B, et al. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology(Berl) 1985; 85(3):367-70.
10Moryl E, Danysz W, Quack G. Potential antidepressive properties of amantadine,memantine and bifemelane. Pharmacol Toxicol 1993; 72(6): 394-7.
